Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View


Neurocrine Biosciences Sees Q4 INGREZZA Sales of ~$240M, FY20 Sales of ~$993M


Benzinga | Jan 8, 2021 07:33AM EST

Neurocrine Biosciences Sees Q4 INGREZZA Sales of ~$240M, FY20 Sales of ~$993M






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC